Mucosal vaccines and technology
Author(s) -
MiquelClopés A.,
Bentley E. G.,
Stewart J. P.,
Carding S. R.
Publication year - 2019
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1111/cei.13285
Subject(s) - infectious disease (medical specialty) , medicine , immunology , mucosal immunity , virology , emerging technologies , intensive care medicine , disease , computer science , immunity , immune system , pathology , artificial intelligence
Summary There is an urgent and unmet need to develop effective vaccines to reduce the global burden of infectious disease in both animals and humans, and in particular for the majority of pathogens that infect via mucosal sites. Here we summarise the impediments to developing mucosal vaccines and review the new and emerging technologies aimed at overcoming the lack of effective vaccine delivery systems that is the major obstacle to developing new mucosal vaccines.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom